CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Société Charles River Laboratories International, Inc.
Actions
CRL
US1598641074
Recherche biotechnologique et médicale
|
Temps réel estimé
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
| 232,5 USD | -1,47 % |
|
-9,67 % | -1,74 % |
Métier
- prestations de services de découverte et d'évaluation de la sécurité (63,4%) : services de découverte pour l'identification, le criblage et la sélection des composés principaux pour le développement de nouveaux candidats-médicaments, et de tests in vivo et in vitro, incluant les études pharmacocinétiques, bioanalytiques, métaboliques, toxicologiques et pathologiques, pour l'évaluation de la sécurité des produits pharmaceutiques, des dispositifs médicaux, des produits de santé animale, des produits chimiques et agrochimiques et des biocides ;
- développement et vente de modèles de recherche et prestations de services connexes (19,2%) : souris, rats, modèles immunodéficients, lapins, cobayes, hamsters, etc. Le groupe propose également des cellules primaires et des produits spécialisés (produits de bioconservation, milieux de congélation pour cultures cellulaires, antigènes, peptides, modèles de souris humanisées, etc.) pour le développement et la fabrication de nouvelles thérapies cellulaires ;
- développement de solutions utilisées dans les processus de fabrication de médicaments (17,5%) : produits et services de tests microbiologiques, de tests in vitro, de tests endotoxines, d'identification microbienne, de développement, de fabrication de vaccins aviaires, etc. Le groupe propose également des services de fabrication sous contrat de thérapies cellulaires et géniques.
Le CA par source de revenus se ventile entre ventes de services (83,3%) et ventes de produits (16,7%).
La répartition géographique du CA est la suivante : Etats-Unis (56,8%), Europe (26,1%), Canada (11,8%), Asie-Pacifique (4,9%) et autres (0,4%).
Nombre d'employés: 21 100
Ventes par activité
| USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
|---|---|---|---|---|---|
Discovery and Safety Assessment
63,3
%
| 2 447 | 61,6 % | 2 616 | 63,3 % | +6,88 % |
Research Models and Services
19,2
%
| 739 | 18,6 % | 792 | 19,2 % | +7,19 % |
Manufacturing Solutions
17,5
%
| 790 | 19,9 % | 721 | 17,5 % | -8,63 % |
Ventes par région
| USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
|---|---|---|---|---|---|
United States
56,8
%
| 2 342 | 58,9 % | 2 347 | 56,8 % | +0,23 % |
Europe
26,1
%
| 1 032 | 26,0 % | 1 077 | 26,1 % | +4,34 % |
Canada
11,8
%
| 399 | 10,0 % | 487 | 11,8 % | +22,14 % |
Asia Pacific
4,9
%
| 193 | 4,8 % | 201 | 4,9 % | +4,15 % |
Other
0,4
%
| 10 | 0,3 % | 17 | 0,4 % | +69,19 % |
Dirigeants
| Dirigeants | Titre | Age | Depuis |
|---|---|---|---|
James Foster
CEO | Chief Executive Officer | 73 | 01/01/76 |
Flavia Pease
DFI | Director of Finance/CFO | 51 | 25/04/22 |
Birgit Girshick
COO | Chief Operating Officer | 54 | 01/04/89 |
Julie Frearson
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/14 |
Mark Mintz
CTO | Chief Tech/Sci/R&D Officer | - | 01/02/21 |
| Compliance Officer | - | 01/02/01 | |
Matthew Daniel
CMP | Compliance Officer | - | 01/01/05 |
Todd Spencer
IRC | Investor Relations Contact | - | 01/06/18 |
Michael Knell
AUD | Comptroller/Controller/Auditor | 47 | 26/04/17 |
John C. Ho
PRN | Corporate Officer/Principal | 64 | 01/01/12 |
Administrateurs
| Administrateurs | Titre | Age | Depuis |
|---|---|---|---|
C. Reese
BRD | Director/Board Member | 78 | 03/12/07 |
George Massaro
BRD | Director/Board Member | 76 | 01/01/03 |
Virginia Wilson
BRD | Director/Board Member | 68 | 01/10/19 |
Robert Bertolini
BRD | Director/Board Member | 61 | 25/01/11 |
Deborah Kochevar
BRD | Director/Board Member | 67 | 29/10/08 |
Richard Wallman
BRD | Director/Board Member | 72 | 24/01/11 |
James Foster
CEO | Chief Executive Officer | 73 | 01/01/76 |
Martin MacKay
BRD | Director/Board Member | 68 | 05/07/17 |
Nancy Andrews
BRD | Director/Board Member | 65 | 28/02/20 |
George Llado
BRD | Director/Board Member | 58 | 16/10/20 |
Classe d'actions
| Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
|---|---|---|---|---|---|
| Action A | 1 | 51 510 790 | 50 578 267 ( 98,19 %) | 0 | 98,19 % |
Coordonnées société
Charles River Laboratories International, Inc.
251 Ballardvale Street
01887, Wilmington
+781 222 6000
http://www.criver.com
Sociétés du groupe
| Nom | Catégorie et Secteur |
|---|---|
Charles River Laboratories, Inc.
 Charles River Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Charles River Laboratories, Inc. provides research models and laboratory animal support services. It offers quality research models and support services to the biomedical community. The company was founded in 1947 and is headquartered in Wilmington, MA. |
Miscellaneous Commercial Services
|
Celsis International Ltd.
 Celsis International Ltd. Medical SpecialtiesHealth Technology Celsis International Ltd. develops and supplies medical diagnostic products and laboratory services. The company was founded by Sir Christopher Evans in 1992 and is headquartered in Westminster, the United Kingdom. |
Medical Specialties
|
Charles River Discovery Research Services Finland Oy
 Charles River Discovery Research Services Finland Oy Miscellaneous Commercial ServicesCommercial Services Charles River Discovery Research Services Finland Oy provides non-clinical central nervous system services to the pharmaceutical and biotechnology industries. The company was founded in 1998 and is located in Kuopio, Finland. |
Miscellaneous Commercial Services
|
Charles River Laboratories Japan, Inc.
 Charles River Laboratories Japan, Inc. Miscellaneous Commercial ServicesCommercial Services Part of The Jackson Laboratory, Charles River Laboratories Japan, Inc. provides laboratory testing and research services. The private company is based in Yokohama, Japan. The Japanese company was founded in 1972. Charles River Laboratories Japan was acquired by The Jackson Laboratory from Charles River Laboratories International, Inc. on October 12, 2021 for $0.56 million. |
Miscellaneous Commercial Services
|
Charles River Laboratories Holdings Ltd.
 Charles River Laboratories Holdings Ltd. Financial ConglomeratesFinance Part of Charles River Laboratories International, Inc., Charles River Laboratories Holdings Ltd. is a British company that provides investment services. The private company is based in Margate, UK and was founded in 1999. |
Financial Conglomerates
|
Charles River UK Ltd.
 Charles River UK Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 1969, Charles River UK Ltd. is a subsidiary of Charles River Laboratories International, Inc. The private company is based in Margate, UK and engages in research and experimental development on biotechnology. |
Miscellaneous Commercial Services
|
Charles River Laboratories Preclinical Services Montreal ULC
 Charles River Laboratories Preclinical Services Montreal ULC Miscellaneous Commercial ServicesCommercial Services Part of Charles River Laboratories International, Inc., Charles River Laboratories Preclinical Services Montreal ULC is a private company based in Senneville, Canada. |
Miscellaneous Commercial Services
|
Charles River Nederland BV
 Charles River Nederland BV Miscellaneous Commercial ServicesCommercial Services Part of Charles River Laboratories International, Inc., Charles River Nederland BV is a private company based in Leiden, the Netherlands. |
Miscellaneous Commercial Services
|
Ballardvale CV
|
Secteur
Ventes par activité
Ventes par région
Révisions de BNA
| Varia. 1 janv. | Capi. | |
|---|---|---|
| -1,39 % | 12,11 Md | |
| +48,77 % | 42,16 Md | |
| -0,15 % | 42,07 Md | |
| +5,41 % | 39,77 Md | |
| -11,36 % | 26,68 Md | |
| +4,35 % | 24,68 Md | |
| -22,94 % | 18,68 Md | |
| +26,62 % | 11,99 Md | |
| +6,11 % | 11,06 Md | |
| -16,91 % | 10,3 Md |
- Bourse
- Actions
- Action CRL
- Société Charles River Laboratories International, Inc.
